Stock search

Ticker or company name

GE HealthCare

GEHC · NASDAQ · Health Care

$82,96Down −0,06 (−0,07%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$37,5 bn
Div. yield
0,2%
Year to date
+1,2%
52 weeks: $58,75$89,77

Ratio score

Not enough data for a score

The score is calculated when at least 6 of 10 metrics are known.

Key metrics

2 ✓ · 0 — · 0 ✕ · 8 n/a

n/aP/E vs its historyLess than 3 years of history17,4
P/E vs industryIndustry median 25,1 · −31%17,4
Forward P/E19% below the current one14,2
n/aRevenue growth, YoYNo data in the reports—
n/aEPS growth, YoYNo data in the reports—
n/aNet marginNo data in the reports—
n/aNet debt / EBITDANo data in the reports—
n/aFree cash flowNo data in the reports—
n/aShare count over a yearNo data in the reports—
n/aCash runwayNo data in the reports—

All metrics

MetricValue5-year medianIndustry median
P/E TTM17,417,925,1
Forward P/E14,2—16,2
PEG1,7—2,2
P/S1,71,82,2
EV/EBITDA14,014,117,3
P/FCF19,9—19,5
P/B3,24,13,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 29 analysts

Buy
21
Hold
8
Sell
0

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,231,34Up +9,1%
Q2 20261,061,13Up +7,0%
Q1 20261,070,99Down −7,5%
Q4 20251,431,44Up +1,0%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $6,42 m (8 people), no sales.

NameAmountSharesPrice
lobo kevin22 May 2026 · open-market purchase$641 80010 000$64,18
hochman rodney f12 May 2026 · open-market purchase$100 3651 618$62,03
yang watkin phoebe l.8 May 2026 · open-market purchase$63 0061 000$63,01
stromberg william j6 May 2026 · open-market purchase$61 6891 000$61,69
culp h lawrence jr6 May 2026 · open-market purchase$5,00 m80 805$61,88
saccaro james1 May 2026 · open-market purchase$200 5853 310$60,60
jimenez frank r30 Apr 2026 · open-market purchase$105 7881 750$60,45
arduini peter j30 Apr 2026 · open-market purchase$249 8274 169$59,93

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NASDAQ
Country
US
IPO date
15 Dec 2022

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
CNCCentene Corporation$74,7772would consider24,2+9,7%0,7%
RMDResMed$238,1983would consider21,3+9,0%27,8%
DXCMDexcom$81,6189would consider31,4+13,0%19,4%
LHLabcorp$372,4656would watch30,0+6,0%6,9%
DGXQuest Diagnostics$262,2161would watch25,5+9,1%9,5%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.